MedTrace Logo

Drawing the Line Between Medium Care and Intensive Care. A Prospective Observational Study Based on the Nursing Activities Score

NCT01633606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2014-01-29

No results posted yet for this study

Summary

The aim of the study is to develop a screening instrument, based on the nursing activities score, by which we can distinguish medium care patients from the intensive care patients in terms of nurse staffing.

The main study question is: What is the most discriminative NAS cut off for medium care patient?

Each nursing shift the NAS and TISS 28 scores will be calculated for each patient who is admitted to the 8 participating units.

Nurses will be asked to answer 3 questions (see detailed description here under)at the end of their working shift concerning each patient appointed to them.

Each morning medical staff and head nurses will be asked 2 questions (see detailed description here under) for concerning patient admitted to there ward.

In order to determine the NAS cut off for medium care patient, all morning questionnaire scores will be compared to the NAS an TISS28 scores of that same morning.

Secondary study questions are:

* Can NAS score based on one nursing shift predict the severity of care in the subsequent nursing shift?
* Is there a difference in appreciation of severity of care between nurses, head nurses and medical staff?
* Which variables influence the perception of severity of care?
* How does NAS relate to TISS28, APACHE and NEMS?

Conditions

  • Critical Illness

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Greet Van den Berghe, MD PhD · Catholic University Leuven

  • Karen Decock, RS · Universitaire Ziekenhuizen KU Leuven

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-09-30
Completion
2013-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01633606 on ClinicalTrials.gov